跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Ticagrelor/Aspirin
首页
药物
Ticagrelor/Aspirin
Ticagrelor/Aspirin
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
TICAGRELOR-CONTAINING PHARMACEUTICAL COMPOSITION
WO 2016169296 A1
申请人: GUANGZHOU NUOWEI BIOTECHNOLOGY COMPANY LTD
优先权: 2015
CN
WO
2 件公开
Medicine composition comprising -grel medicine and aspirin salt
CN 102755336 A
申请人: KAO FU
优先权: 2011
CN
Novel anti-coagulation medicinal composition
CN 102247346 A
申请人: BEIJING FUKANGREN BIOPHARMACEUTICAL TECHNOLOGY CO LTD
优先权: 2011
CN
Aspirin and anticoagulant pharmaceutical composition
CN 102228691 A
申请人: BEIJING FUKANGREN BIOPHARMACEUTICAL TECHNOLOGY CO LTD
优先权: 2011
CN
Oral nano composition of ticagrelor
CN 104971070 A
申请人: UNIV BEIJING
优先权: 2014
CN
Compound oral solid preparation containing ticagrelor and aspirin and preparation method of solid preparation
CN 104434931 A
申请人: NANJING HUAWE MEDICAL TECHNOLOGY DEV CO LTD
优先权: 2014
CN
Preparation method of compound oral solid preparation containing Ticagrelor
CN 107260700 A
申请人: XIAMEN ENCHENG PHARMACEUTICAL CO LTD
优先权: 2016
CN
Application of Naoxintong traditional Chinese medicine composition in preparation of medicine for treating cerebral hemorrhage
CN 106728119 A
申请人: UNIV SUN YAT SEN
优先权: 2017
CN
Compound packaged preparation containing ticagrelor and aspirin
CN 111991399 A
申请人: LEPU MED TECH BEIJING CO LTD
优先权: 2020
CN
Compound preparation containing ticagrelor and aspirin and preparation method of compound preparation
CN 111939136 A
申请人: LEPU MEDICAL BEIJING MEDICAL INSTR CO LTD
优先权: 2020
CN
第 1 / 2 页
上一页
下一页
药物
反馈